Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphatic Drug Delivery to Metastatic Neck Lymph Nodes in Head and Neck Cancer (Phase I Safety Study)
jRCTs021230040Phase 1Not yet recruiting
- Start
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in head and neck cancer (HNC) and metastatic malignant neoplasm in lymph node (LNM). Primary endpoint: Frequency of adverse events related to LDDS anti-tumor agent injection. Planned start Dec 2025; status: not yet recruiting.
02
Conditions
head and neck cancer (HNC)metastatic malignant neoplasm in lymph node (LNM)
Beyond the preview
Go deeper on jRCTs021230040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021230040.